Tandem Diabetes Care Inc. (TD5A)
Munich
18.70
-0.50 (-2.60%)
Closed
Aug 26, 2026
Day's Range
18.7018.70
52 wk Range
10.1224.21
Financial Statements - TD5A - Tandem Diabetes Care Inc.
Revenue
1.01B▲ 27.4%
Net Income
-204.71M▼ 151.7%Net Margin -20.2%
EBITDA
-156.60M▼ 170.0%
Free Cash Flow
-108.25M▼ 2659.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.01B | 796.40M | 747.71M | 801.21M | 702.79M | 498.83M |
| Cost of Goods | 468.72M | 381.70M | 380.02M | 388.23M | 326.58M | 238.31M |
| Gross Profit | 546.01M | 414.69M | 367.69M | 412.98M | 376.21M | 260.52M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -167.30M | -83.96M | -154.48M | -61.80M | 22.65M | -7.95M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -34.14M | -2.81M | -78.75M | -30.89M | -1.38M | -17.08M |
| Pre Tax Income | -200.27M | -77.81M | -220.25M | -92.85M | 15.90M | -36.28M |
| Income Tax | 4.43M | 3.51M | 2.35M | 1.74M | 335K | -1.90M |
| Net Income | -204.71M | -81.33M | -222.61M | -94.59M | 15.56M | -34.38M |
| EPS Basic | -3.04 | -1.47 | -3.43 | -1.47 | 0.25 | -0.56 |
| EPS Diluted | -3.04 | -1.47 | -3.43 | -1.47 | 0.24 | -0.56 |
| Basic Shares Outstanding | 67.28M | 55.44M | 67.61M | 66.75M | 65.56M | 63.47M |
| Diluted Shares Outstanding | 67.28M | 55.44M | 67.61M | 66.75M | 65.56M | 63.47M |
| Ebit | -194.22M | -73.15M | -212.68M | -88.53M | 20.21M | -24.12M |
| Ebitda | -156.60M | -58.01M | -118.22M | -43.31M | 35.44M | 3.40M |
| Net Income Continuous Operations | -204.71M | -81.33M | -222.61M | -94.59M | 15.56M | -34.38M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
